Oxford University and AstraZeneca became the first Covid-19 vaccine makers to publish final-stage clinical results

Yesterday, by clearing a key hurdle in the global race to produce safe and effective drugs for the new coronavirus, Oxford University and AstraZeneca became the first Covid-19 vaccine makers to announce final-stage clinical trial results in a scientific journal.

Andrew Pollard, the director of the Oxford Vaccine Group said, “A range of vaccines would be needed to bring the pandemic to heel, otherwise we’ll still be in this position in six months time”. He added, “I think it is fair to say it needs more looking into to explain the intriguing result.” He further said, “Moreover it did not contain any older participants and it remains possible that if the regulators allowed the vaccine to be used in this manner, the most at-risk group may not be protected.”

The study stated there had been no hospitalizations or severe disease reported in the Covid-19 vaccine group so far.